Filters

Equine herpesvirus 1 Serine/threonine-protein kinase US3 homolog (69)

Equine herpesvirus 1 Serine/threonine-protein kinase US3 homolog (69) size: 100ug 2083

Supplier MBS RECOMBINANT PROTEINS
Price 2083
Size 100ug
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long nameRecombinant Equine herpesvirus 1 Serine/threonine-protein kinase US3 homolog (69)
Alternative names Serine/threonine-protein kinase US3 homolog, mediates phosphorylation of HDAC1 and HDAC2 and other cellular and viral proteins, phosphorylates nuclear egress lamina protein, serine/threonine protein kinase US3, tegument protein, serine/threonine protein kinase US3
Gene nameN/A
Other gene names 69, ORF69
General description All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, Serine/threonine-protein kinase US3 homolog (69) is a recombinant protein expressed in Baculovirus
Product categoryRecombinant Proteins
Expression systemBaculovirus
Available also expressed in: Baculovirus , Mammalian Cell, Yeast , E Coli
PurityGreater than 90% (determined by SDS-PAGE)
FormLyophilized protein
Storage Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius
Applications IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA
Gene targetEquine herpesvirus 1 Serine/threonine-protein kinase US3 homolog (69)
Short nameEquine herpesvirus 1 Serine/threonine-protein kinase US3 homolog (69)
Alternative namehorse herpesvirus 1 Serine/threonine-protein phosphorylation catalyst US3 homolog (69)

Similar products

Subscribe to our Newsletter